Page last updated: 2024-11-06

corticosterone and Porphyria, Acute Intermittent

corticosterone has been researched along with Porphyria, Acute Intermittent in 1 studies

Porphyria, Acute Intermittent: An autosomal dominant porphyria that is due to a deficiency of HYDROXYMETHYLBILANE SYNTHASE in the LIVER, the third enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features are recurrent and life-threatening neurologic disturbances, ABDOMINAL PAIN, and elevated level of AMINOLEVULINIC ACID and PORPHOBILINOGEN in the urine.

Research Excerpts

ExcerptRelevanceReference
"In this acute porphyria model, gluconeogenic and glycogenolytic blockages caused by PEPCK and GP depressed activities, respectively, would be mainly a consequence of the negative regulatory action of insulin on these enzymes."1.37How porphyrinogenic drugs modeling acute porphyria impair the hormonal status that regulates glucose metabolism. Their relevance in the onset of this disease. ( D'Andrea, F; Fornes, D; Matkovic, LB; Mazzetti, MB; San Martín de Viale, LC, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matkovic, LB1
D'Andrea, F1
Fornes, D1
San Martín de Viale, LC1
Mazzetti, MB1

Other Studies

1 other study available for corticosterone and Porphyria, Acute Intermittent

ArticleYear
How porphyrinogenic drugs modeling acute porphyria impair the hormonal status that regulates glucose metabolism. Their relevance in the onset of this disease.
    Toxicology, 2011, Nov-28, Volume: 290, Issue:1

    Topics: Adrenocorticotropic Hormone; Animals; Corticosterone; Disease Models, Animal; Female; Glucose; Porph

2011